chartexchange

Ultragenyx Q3 Loss Narrows; Reaffirms 2027 Profit Outlook

RTTNews | Nov 3, 2026 4:24 PM EST


(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE), a biopharmaceutical company focused on developing therapies for serious rare and ultra-rare genetic diseases, on Tuesday reported a narrower loss for the third quarter of 2026, driven by higher revenues and lower research and dev

Read original article